PRESS RELEASE published on 11/21/2024 at 17:45, 1 year ago Amoéba announces the publication of a first scientific article on the efficacy of its innovation in cosmetics Amoéba announces publication of a scientific article on the efficacy of Willaertia lysate in Cosmetics journal. Discover the natural microbiological solution's benefits for skin anti-aging AMOEBA Willaertia Lysate Cosmetics Journal Skin Anti-aging Microbiological Solution
BRIEF published on 10/07/2024 at 17:50, 1 year 1 month ago Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024 AMOEBA Investors Financial Report Biocontrol Cosmetic
PRESS RELEASE published on 10/07/2024 at 17:45, 1 year 1 month ago Amoéba: Publication of the half-year financial report at 30 June 2024 Amoéba announces the publication of its half-year financial report for 2024 and upcoming institutional investor event. Amoéba, a greentech company, provides natural microbiological solutions AMOEBA Investor Event Half-year Financial Report GreenTech Microbiological Solutions
BRIEF published on 10/03/2024 at 17:50, 1 year 2 months ago Amoéba confirms its strategic pivot in the first half of 2024 AMOEBA Strategy Biocontrol GreenTech Cosmetic
PRESS RELEASE published on 10/03/2024 at 17:45, 1 year 2 months ago Amoéba: the first half of 2024 confirms the strategic pivot towards an industrial and commercial company from 2025 onwards Amoéba reports strategic shift to commercial focus & positive operating income growth in H1 2024. Financial outlook secured until mid-2025. Development plans for biocontrol & cosmetics segments AMOEBA Financial Results Biocontrol Cosmetics Strategic Shift
BRIEF published on 10/02/2024 at 17:50, 1 year 2 months ago AMOEBA: Total number of voting rights and shares as of September 30, 2024 AMOEBA Voting Rights Capital Actions Financial Markets
BRIEF published on 08/28/2024 at 17:50, 1 year 3 months ago Amoéba Prepares for US Launch of AXPERA Product Line by 2025 Market Authorization 2025 Targets AXPERA Launch EPA Approval Biocontrol Products
PRESS RELEASE published on 08/28/2024 at 17:45, 1 year 3 months ago AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025 Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress AMOEBA Collaboration Market Authorization Biofungicide US EPA
BRIEF published on 07/02/2024 at 08:35, 1 year 5 months ago AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES AMOEBA Biocontrol Cosmetics Legal Reorganisation Subsidiary
REGULATED PRESS RELEASE published on 07/02/2024 at 08:30, 1 year 5 months ago AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES Amoéba announces a reorganisation to enhance commercial activities in biocontrol and cosmetics sectors, aiming to create value for shareholders. New legal structure to optimize resources and facilitate partnerships AMOEBA Biocontrol Cosmetics Legal Structure Commercial Activities
Published on 12/05/2025 at 02:35, 10 hours 39 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 14 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 9 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 14 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 14 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 14 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 9 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 14 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 14 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 29 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 14 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 29 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 30 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health